Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹513 Cr.
Stock P/E
8.1
P/B
0.3
Current Price
₹720
Book Value
₹ 2122.2
Face Value
10
52W High
₹862
52W Low
₹ 405
Dividend Yield
0.42%

Riddhi Siddhi Gluco Overview

Business

Riddhi Siddhi Gluco Biols Ltd. operates primarily in the trading sector in India. The company is involved in the buying, selling, and distribution of various commodities and industrial products, often specializing in those related to glucose, starch, and other bio-based derivatives. Its core business model revolves around sourcing these products from manufacturers or primary markets and supplying them to various end-user industries such as food & beverage, pharmaceuticals, textiles, and paper, leveraging its network and logistics capabilities. The company generates revenue by earning a margin on the trading activities, i.e., the difference between its purchase price and sales price of goods traded.

Revenue Mix

While specific revenue percentages are not publicly detailed, Riddhi Siddhi Gluco Biols Ltd.'s primary activities would fall under the broad category of trading. Based on its name and industry focus, key product segments likely include:

Starch and Starch Derivatives Trading: This would encompass products like liquid glucose, dextrose monohydrate, maltodextrin, various starches (e.g., maize starch, potato starch), and modified starches.

Other Industrial Chemicals/Commodities Trading: Potentially includes other bio-based chemicals or agricultural commodities relevant to the industries they serve.

The company's revenue mix is entirely driven by its trading volumes and the margins achieved on different product categories.

Industry

The company operates in the broader Indian trading industry, specifically focusing on industrial commodities like starches and glucose derivatives. This is a highly fragmented and competitive industry characterized by numerous players ranging from small regional traders to larger, integrated distributors. Competition is primarily based on price, supply reliability, credit terms, and established relationships. Riddhi Siddhi Gluco Biols likely positions itself by leveraging its established network, sourcing capabilities, and understanding of the specific market dynamics for "Gluco Biols" products, aiming to serve niche or specific industrial clients in India.

MOAT

Trading companies typically possess limited structural moats compared to manufacturing or technology firms. For Riddhi Siddhi Gluco Biols, potential competitive advantages, if any, would likely stem from:

Established Relationships: Long-standing ties with both suppliers and customers can provide a stable base for operations.

Supply Chain & Logistics Efficiency: An optimized network for sourcing, warehousing, and distribution can offer cost advantages and reliability.

Market Niche Expertise: Specialization in specific products like glucose and starch derivatives provides deeper understanding and potentially better pricing within that niche.

Working Capital Management: Efficient management of working capital is crucial in trading and can be a subtle advantage.

However, these are generally not considered strong, durable moats, as barriers to entry for new traders are relatively low, and competition can easily erode margins.

Growth Drivers

Growth in End-User Industries: Increased demand from the food & beverage, pharmaceutical, textile, and paper industries in India will directly drive demand for the products the company trades.

Expansion of Product Portfolio: Introducing new related commodities or industrial chemicals to their trading portfolio can open new revenue streams.

Geographic Expansion: Expanding reach to new regions or states within India.

Supply Chain Optimization: Improvements in sourcing, logistics, and inventory management can lead to higher efficiency and better margins.

Favorable Commodity Cycles: Upward trends in the prices of traded commodities, managed effectively, can boost top-line growth.

Risks

Commodity Price Volatility: Fluctuations in the prices of glucose, starch, and other traded commodities can significantly impact trading margins and profitability.

Intense Competition: The fragmented nature of the trading industry leads to intense price competition, which can pressure margins.

Supply Chain Disruptions: Issues in sourcing (e.g., crop failures, manufacturing outages) or logistics (e.g., transportation strikes, port congestion) can halt operations and impact profitability.

Working Capital Management: Trading businesses typically require significant working capital. Inefficient management or delays in receivables can strain liquidity.

Credit Risk: Risk of default or delayed payments from customers, especially during economic downturns.

Regulatory and Trade Policies: Changes in import/export duties, tariffs, or other trade policies can impact sourcing costs and market competitiveness.

Management & Ownership

As is common with many Indian companies in the trading sector, Riddhi Siddhi Gluco Biols Ltd. is typically promoted and managed by its founding family or a close-knit group. The promoter group likely holds a significant ownership stake, aligning their interests with the company's long-term performance. The quality of management would depend on their experience in commodity trading, financial prudence, ability to navigate market cycles, and strategic vision for growth and diversification within the trading segment. Specific details about management quality and track record would require reviewing their annual reports and public disclosures.

Outlook

Riddhi Siddhi Gluco Biols operates in a foundational but competitive sector. The company's outlook is closely tied to the underlying growth of industrial consumption in India, particularly within its key end-user segments like food and pharmaceuticals. A favorable macroeconomic environment, coupled with the company's ability to maintain strong supplier and customer relationships, efficient logistics, and prudent working capital management, could support stable operational performance and incremental growth. However, the inherent volatility of commodity prices and intense competition in the trading industry will remain significant challenges. The company's success will largely depend on its agility in adapting to market fluctuations, effective risk management, and its ability to continually optimize its trading margins amidst a low-margin business environment.

Riddhi Siddhi Gluco Share Price

Live · BSE · Inception: 1990
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Riddhi Siddhi Gluco Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 51 14 49 44 28 155 32 40 9 90
Other Income 16 20 21 20 26 21 22 14 11 17
Total Income 67 34 70 65 54 176 54 54 20 107
Total Expenditure 54 14 42 45 31 155 31 46 17 93
Operating Profit 13 20 28 19 23 21 24 9 3 14
Interest 2 2 3 3 3 4 5 4 4 6
Depreciation 3 2 2 2 2 2 2 2 2 2
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 9 16 23 15 18 15 16 2 -4 6
Provision for Tax -20 -10 8 -4 15 6 1 2 1 2
Profit After Tax 29 26 15 19 3 10 15 0 -5 4
Adjustments -6 -2 -2 -55 1 -1 -1 -2 -21 -1
Profit After Adjustments 23 24 13 -36 4 8 14 -1 -26 3
Adjusted Earnings Per Share 32.2 33.8 18.9 -50.6 5.1 11.6 19.5 -1.6 -35.8 4.6

Riddhi Siddhi Gluco Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 342 508 804 682 576 498 223 173 268 136 171
Other Income 134 118 335 70 50 59 62 68 81 88 64
Total Income 476 626 1139 752 627 557 285 241 349 223 235
Total Expenditure 349 560 1073 605 529 511 200 173 265 134 187
Operating Profit 127 66 66 147 98 45 85 68 84 90 50
Interest 33 52 62 40 31 26 8 8 9 10 19
Depreciation 35 35 34 35 37 37 13 12 11 9 8
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 59 -21 -30 73 30 -18 64 48 65 71 20
Provision for Tax 15 25 -39 6 6 44 16 15 8 8 6
Profit After Tax 44 -45 9 67 24 -62 49 33 57 63 14
Adjustments -4 3 10 -19 9 15 -34 -89 -10 -58 -25
Profit After Adjustments 40 -43 19 49 33 -47 14 -56 47 5 -10
Adjusted Earnings Per Share 56.3 -60 26.6 68.3 46.1 -65.6 20.1 -77.9 65.5 7.3 -13.3

Riddhi Siddhi Gluco Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 1367 1323 1389 1436 1425 1453 1504 1432 1537 1549
Minority's Interest 107 178 168 165 133 99 87 58 55 38
Borrowings 226 189 165 116 85 80 72 1 1 0
Other Non-Current Liabilities 29 43 4 -7 -24 16 18 11 14 16
Total Current Liabilities 347 640 416 357 340 292 156 96 92 119
Total Liabilities 2075 2373 2142 2066 1959 1941 1838 1692 1774 1784
Fixed Assets 783 769 744 723 748 770 738 392 383 434
Other Non-Current Assets 169 257 328 408 228 571 561 573 713 740
Total Current Assets 1123 1347 1070 935 983 600 539 490 454 464
Total Assets 2075 2373 2142 2066 1959 1941 1838 1692 1774 1784

Riddhi Siddhi Gluco Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 43 31 30 8 17 72 4 0 11 0
Cash Flow from Operating Activities 0 -284 -34 -1 116 130 161 1 9 -28
Cash Flow from Investing Activities -67 65 269 163 30 -91 -71 8 21 21
Cash Flow from Financing Activities -55 192 -263 -169 -131 -108 -94 2 -41 8
Net Cash Inflow / Outflow -122 -27 -28 -7 15 -69 -3 11 -11 -0
Closing Cash & Cash Equivalent 2 4 1 1 32 3 0 11 0 0

Riddhi Siddhi Gluco Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 56.3 -59.99 26.58 68.31 46.11 -65.62 20.09 -77.9 65.5 7.3
CEPS(Rs) 110.09 -14.69 60.43 142.91 85.05 -34.13 86.21 63.29 95.28 100.39
DPS(Rs) 3 2 0 2 0 0 1 1.5 3 3
Book NAV/Share(Rs) 1916.82 1855.36 1947.59 2013.04 1998.12 2037.66 2110.1 2008.5 2155.46 2172.72
Core EBITDA Margin(%) -2.08 -10.12 -33.44 11.28 8.25 -2.74 10.3 0.09 1.26 1.47
EBIT Margin(%) 26.82 6.13 3.95 16.52 10.66 1.58 32.15 32.39 27.45 59.95
Pre Tax Margin(%) 17.21 -4.04 -3.74 10.69 5.25 -3.63 28.78 28.01 24.15 52.75
PAT Margin (%) 12.79 -8.89 1.1 9.86 4.18 -12.42 21.82 19.31 21.34 46.53
Cash Profit Margin (%) 22.88 -2.05 5.36 14.95 10.52 -4.89 27.53 26.09 25.35 52.82
ROA(%) 2.12 -2.04 0.39 3.2 1.2 -3.17 2.58 1.89 3.3 3.54
ROE(%) 3.21 -3.37 0.65 4.76 1.68 -4.3 3.29 2.27 3.85 4.09
ROCE(%) 5.08 1.64 1.64 6.17 3.53 0.47 4.3 3.53 4.71 4.99
Receivable days 148.45 66 21.54 26.49 93.5 127.84 124.76 98.66 44.78 47.29
Inventory Days 34.39 144 167.42 217.22 205.64 155.58 224.25 64.22 6.42 66.32
Payable days 201.05 132.42 55.47 73.6 81.77 77.52 143.83 86.09 14.25 29.29
PER(x) 5.51 0 23.51 4.83 4.32 0 17.19 0 7.7 71.87
Price/Book(x) 0.16 0.24 0.32 0.16 0.1 0.12 0.16 0.17 0.23 0.24
Dividend Yield(%) 0.97 0.45 0 0.61 0 0 0.29 0.45 0.59 0.57
EV/Net Sales(x) 1.94 1.96 1.14 0.86 0.66 0.81 1.79 1.78 1.6 3.49
EV/Core EBITDA(x) 5.23 15.03 13.92 3.96 3.86 8.85 4.73 4.54 5.1 5.27
Net Sales Growth(%) 0 48.56 58.24 -15.19 -15.48 -13.65 -55.13 -22.55 54.96 -49.43
EBIT Growth(%) 0 -66.03 1.54 254.7 -45.47 -87.2 813.19 -21.98 31.32 10.45
PAT Growth(%) 0 -203.25 119.58 657.92 -64.19 -356.68 178.82 -31.46 71.28 10.25
EPS Growth(%) 0 -206.57 144.31 156.99 -32.5 -242.3 130.62 -487.71 184.09 -88.86
Debt/Equity(x) 0.33 0.52 0.34 0.25 0.19 0.16 0.1 0.06 0.05 0.06
Current Ratio(x) 3.24 2.1 2.57 2.62 2.89 2.05 3.46 5.12 4.94 3.89
Quick Ratio(x) 3.15 1.53 1.69 1.38 2.29 1.31 3.1 5.07 4.88 3.52
Interest Cover(x) 2.79 0.6 0.51 2.84 1.97 0.3 9.54 7.39 8.31 8.33
Total Debt/Mcap(x) 2.01 2.16 1.06 1.5 1.9 1.29 0.63 0.34 0.2 0.27

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -49% -15% -25% —
Operating Profit CAGR +7% +2% -2% —
PAT CAGR +11% +9% +21% —
Share Price CAGR +27% +21% +14% +7%
ROE Average +4% +3% +2% +2%
ROCE Average +5% +4% +4% +4%

Riddhi Siddhi Gluco Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 75 %
FII 2.67 %
DII (MF + Insurance) 0.01 %
Public (retail) 22.32 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 74.5474.5474.5474.5474.5474.5474.5486.557575
FII 000000002.672.67
DII 0.010.010.010.010.010.010.010.010.010.01
Public 25.4525.4525.4525.4525.4525.4525.4513.4422.3222.32
Others 0000000000
Total 100100100100100100100100100100

Riddhi Siddhi Gluco Peer Comparison

Riddhi Siddhi Gluco Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Riddhi Siddhi Gluco Pros & Cons

Pros

  • Stock is trading at 0.3 times its book value
  • Company has delivered good profit growth of 21% CAGR over last 5 years
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 3% over the last 3 years.
  • Debtor days have increased from 14.25 to 29.29days.
  • Earnings include an other income of Rs. 88 Cr.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp